Compare Mutual Funds
Select a Mutual Fund
Risk | Very High | - |
Rating | 2.0 | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 2.3 | - |
NAV | ₹30.46 | - |
Fund Started | 20 Jun 2019 | - |
Fund Size | ₹837.41 Cr | - |
Exit Load | Exit load of 1% if redeemed within 30 days. | - |
Risk
Very High
-
Rating
2.0
-
Min SIP Amount
₹100
-
Expense Ratio
2.3
-
NAV
₹30.46
-
Fund Started
20 Jun 2019
-
Fund Size
₹837.41 Cr
-
Exit Load
Exit load of 1% if redeemed within 30 days.
-
1 Year | 0.86% | - |
3 Year | 21.20% | - |
5 Year | 12.74% | - |
1 Year
0.86%
-
3 Year
21.20%
-
5 Year
12.74%
-
Equity | 98.81% | - |
Cash | 1.19% | - |
Equity
98.81%
-
Cash
1.19%
-
Top 10 Holdings |
| - |
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.47% |
Apollo Hospitals Enterprise Ltd. | 7.14% |
Cipla Ltd. | 6.08% |
Torrent Pharmaceuticals Ltd. | 4.71% |
JB Chemicals & Pharmaceuticals Ltd. | 4.51% |
Abbott India Ltd. | 4.48% |
Ajanta Pharma Ltd. | 4.28% |
Aurobindo Pharma Ltd. | 4.11% |
Fortis Healthcare Ltd. | 3.99% |
Lupin Ltd. | 3.94% |
-
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. | - |
Launch Date | 20 Jun 2019 | - |
Description
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
-
Launch Date
20 Jun 2019
-